US Oncology Image About Us | Careers | Contact Us | News Room

Home > Oncologist Home > US Oncology Research > US Oncology Research Trials
US Oncology Research Trials
US Oncology Research provides novel therapies to patients in the community setting and allows participatation in landmark clinical trials. Use the search function below to view all open trials currently being conducted by US Oncology Research.



CLINICAL TRIAL SEARCH RESULTS
Trial Number: NCT02128282
Cancer Type: Biliary Cancer

A Phase I/II Study of CX-4945 in Combination with Gemcitabine plus Cisplatin in the Frontline Treatment of Patients with Cholangiocarcinoma (S4-13-001)
Read More


Trial Number: NCT01772004
Cancer Type: Bladder Cancer

(EMR 100070-001) A Phase I, open-label, multiple-ascending dose trial to investigate the safety, tolerability, pharmacokinetics, biological and clinical activity of MSB0010718C in subjects with metastatic or locally advanced solid tumors and expansion to selected indications
Read More


Trial Number: NCT 02108652
Cancer Type: Bladder Cancer

A PHASE II, MULTICENTER, SINGLE-ARM STUDY OF MPDL3280A IN PATIENTS WITH LOCALLY ADVANCED OR METASTATIC UROTHELIAL BLADDER CANCER - Roche GO29293
Read More


Trial Number: NCT01781455
Cancer Type: Bladder Cancer

A Phase 1 Clinical Study of BBI503 in Adult Patients with Advanced Solid Tumors (BBI503-101)
Read More


Trial Number: NCT01421524
Cancer Type: Brain Cancer

A Phase 1A/1B, Multi-Center, Open-Label, Dosing finding study to assess the safety, tolerability, pharmacokinetics and preliminary efficacy of the pleiotropic pathway modifier CC-122 administered orally to subjects with advanced solid tumors, non-Hodgkin’s lymphoma or multiple myeloma (CC-122-ST-001)
Read More

Bookmark and Share
Print E-Mail Text Size Smaller text size Larger text size
US ONCOLOGY VIDEO
  • US Oncology Research : US Oncology Research is now one of the largest community-based research programs in the U.S. Over the years more than 50,000 patients have participated in over 1,200 clinical trials in our program.
  • Advancing the Science of Care : Investigators in The US Oncology Network advance the science of cancer treatment to enhance patient care.
  • Expanding Patient Access to Quality Care : McKesson Specialty Health and The US Oncology Network will align resources to make sure that patients receive the best care.
  • Emphasis on Clinical Integrity : Physicians and clinicians in The US Oncology Network play an integral role in keeping The Network at the clinical forefront
  • Strengthening Community Care : McKesson Specialty Health President, Marc Owen, discusses the strengths of community-based cancer care.
  • Proving Outcomes with Health Information Technology : Health Information Systems make it possible to prove outcomes in a large patient population
  • Changing Patient Care through the US Oncology Research Network : Dr. Daniel Von Hoff highlights the commitment of the US Oncology Research Network investigators
  • Healthcare Technology Enhancing Quality Patient Care : Improving patient care and safety with an electronic health record
  • What is iKnowMed : How iKnowMed stands out from other Electronic Health Record systems
  • Enabling Personalized Medicine through Network Collaboration : Delivering personalized, precision medicine with the US Oncology Research Network
  • Solutions for the Independent Oncology Practice : Learn how US Oncology can provide varying levels of support to community oncology practices
  • Addressing the Complexities of Cancer Care with an EHR : How an EHR can improve patient care
  • Community Clinical Trials Essential in Delivering Evidence-based Medicine : Learn how evidence-based medicine is impacted by research conducted in the community setting
  • Physician Collaboration to Advance the Science of Cancer Care  : Learn how cross-country collaboration is made possible through the United Network of US Oncology
  • Benefits of Participating in a Nationwide Physician Network : A large network makes it possible to collaborate with experts across the nation on a daily basis
  • Research Needed for Community Oncology to Thrive : Offering Research in the community oncology setting benefits patients
  • Advocating for Pay-for-Performance Opportunities as a United Network : Pay-for-Performance is most likely to happen for a United Network
  • Validating the Value of Level I Pathways : Understanding How Evidence Based Guidelines for Cancer Care Are Developed and What They Mean
View Larger >
Global Navigation
About Us
Careers
Contact Us
News
Blog
Choose Your Path
Patients
Oncologists
Referring Physicians
Cancer Care Advocates
Legal and Policy
Terms of Use
For Employees
Sitemap
Technical Help
Follow Us:
Twitter YouTube
© 2014 McKesson Specialty Health. All rights reserved.